The company in question is, Grifols, S.A. (NASDAQ:GRFS) currently with a stock price of 16.93 (0.12% today). The market cap for Grifols, S.A. is 23166.7, and is in the sector Healthcare, and Biotechnology industry. The target price for Grifols, S.A. is 15. Currently Grifols, S.A. is trading with a P/E of 38.43, and a forward P/E of 14.83. Average volume for Grifols, S.A. is 1256.1 and so far today it is 283848.
Performance in the last year for Grifols, S.A. has been 8.25%. For EPS growth, Grifols, S.A. has seen a growth of 3.00%, and is looking to grow in the next year to 10.70%. More long term stats show that EPS growth has been 39.67% over the last five years and could be 15.00% for the next five years. Grifols, S.A. has seen sales growth quarter over quarter at 5.60%, with EPS growth quarter over quarter at -2.50%. The 20-day simple moving average is 5.20%, with the 200-day simple moving average coming to 6.99%.
Since the IPO date for Grifols, S.A. on the 6/2/2011, Grifols, S.A. has seen performance year to date to be 5.37%. With Grifols, S.A. trading at 16.93, the dividend yield is 3.08%, and the EPS is 0.44.
So could Grifols, S.A., be undervalued? Well as said before P/E is 38.43. The PEG is 2.56, P/S is 5.25 and the P/B is at 6.36. The P/cash is *TBA, with P/free cash flow at *TBA.
Grifols, S.A. ability to deal with debt shows that the current ratio is *TBA, and the quick ratio is *TBA. This is with long term debt/equity at *TBA, and total debt/equity at *TBA.
In terms of margins, Grifols, S.A. has a gross margin of *TBA, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Grifols, S.A. is *TBA. Return on assets come to *TBA with return on investment coming to *TBA.
Insider ownership for Grifols, S.A., is at *TBA and institutional ownership comes to *TBA. Outstanding shares are at 1370. While shares float is 1100. The float short is currently 0.12%, and short ratio is 1.09.